Zantac / Ranitidine (NDMA Cancer) Lawsuit in Maryland

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Written By
People's Justice Legal Research Team

Statute of Limitations

Maryland has a 3-year statute of limitations for personal injury claims (Md. Code Ann., Cts. & Jud. Proc. § 5-101) with the discovery rule. Maryland applies contributory negligence in tort cases, but pharmaceutical strict product liability claims do not typically involve claimant fault as a complete bar. Maryland courts apply a version of the Frye-Reed standard for novel scientific evidence — similar to the general acceptance test used in Delaware — potentially more favorable than Daubert for Zantac causation experts.

3 years from date of cancer diagnosis discovery (Frye-Reed standard — potentially favorable)

Maryland Data

Exposure in Maryland

Source: U.S. Census Bureau 2024

Source: Maryland Cancer Registry 2024

Source: Maryland evidentiary law — Reed v. State

Medical Resources

Clinics & Specialists in Maryland

Johns Hopkins Kimmel Cancer Center

University of Maryland Greenebaum Comprehensive Cancer Center

Back to Zantac / Ranitidine (NDMA Cancer) Lawsuit Overview